نتائج البحث - "Glucagon-Like Peptide-1 Receptor"

1

Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study

المؤلفون: Yuichiro Yamada, Kenta Murotani, Yusuke Seino, Yutaka Seino, Minori Ishitobi, Yuji Yamazaki, Yuuka Fujiwara, Ryota Usui, Yoshiyuki Hamamoto, Hitoshi Kuwata, Sodai Kubota, Daisuke Yabe, Takeshi Kurose, Takuya Haraguchi, Saki Kubota-Okamoto

المصدر: Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 12, Iss 12, Pp 2162-2171 (2021)

مصطلحات موضوعية: Blood Glucose, Male, 0301 basic medicine, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Glucagon-Like Peptides, Gastric emptying, Type 2 diabetes, chemistry.chemical_compound, 0302 clinical medicine, Japan, Insulin, Prospective Studies, digestive, oral, and skin physiology, Articles, General Medicine, Middle Aged, Postprandial Period, Clinical Science and Care, Postprandial, GLP‐1 receptor agonist, Female, Original Article, hormones, hormone substitutes, and hormone antagonists, medicine.drug, Adult, endocrine system, medicine.medical_specialty, Recombinant Fusion Proteins, 030209 endocrinology & metabolism, Gastric Inhibitory Polypeptide, Diseases of the endocrine glands. Clinical endocrinology, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, Internal medicine, islet hormones, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Glucagon-like peptide 1 receptor, Liraglutide, business.industry, RC648-665, Glucagon, medicine.disease, Immunoglobulin Fc Fragments, 030104 developmental biology, Endocrinology, Diabetes Mellitus, Type 2, chemistry, Dulaglutide, Apolipoprotein B-48, Peptides, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306175bf3a5c32c1eda622a58314861dTest
https://doi.org/10.1111/jdi.13598Test

2

GLP-1R agonists for the treatment of obesity: a patent review (2015-present)

المؤلفون: Hai Qian, Chunxia Liu, Yuxing Zou

المصدر: Expert Opinion on Therapeutic Patents. 30:781-794

مصطلحات موضوعية: endocrine system, medicine.medical_specialty, medicine.medical_treatment, Glucagon-Like Peptides, Peptide, Endogeny, Enteroendocrine cell, 01 natural sciences, Glucagon, Glucagon-Like Peptide-1 Receptor, Patents as Topic, 03 medical and health sciences, 0302 clinical medicine, Glucagon-Like Peptide 1, Internal medicine, Drug Discovery, medicine, Animals, Humans, Obesity, Receptor, Pharmacology, chemistry.chemical_classification, Insulin, digestive, oral, and skin physiology, General Medicine, Liraglutide, medicine.disease, 0104 chemical sciences, 010404 medicinal & biomolecular chemistry, Endocrinology, chemistry, 030220 oncology & carcinogenesis, Glucose-dependent insulinotropic polypeptide, Anti-Obesity Agents, Peptides, hormones, hormone substitutes, and hormone antagonists

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3afe6c00ed95b9c0aebc29e6077897d7Test
https://doi.org/10.1080/13543776.2020.1811851Test

3

Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation

المؤلفون: Paul J. Emmerson, David J. Hodson, Brandy M. Snider, Nicolas Nunn, Tamer Coskun, Jenna Hunter, Mehdi Boutagouga Boudjadja, Gabriella Aviello, Isabella Culotta, Minrong Ai, Simon M. Luckman, Alessia Costa, Giuseppe D'Agostino, Lourdes Valencia-Torres

المساهمون: Costa, A., Ai, M., Nunn, N., Culotta, I., Hunter, J., Boudjadja, M. B., Valencia-Torres, L., Aviello, G., Hodson, D. J., Snider, B. M., Coskun, T., Emmerson, P. J., Luckman, S. M., D'Agostino, G.

المصدر: Costa, A, Ai, M, Nunn, N, Culotta, I, Hunter, J, Boudjadja, M B, Valencia-Torres, L, Aviello, G, Hodson, D J, Snider, B M, Coskun, T, Emmerson, P J, Luckman, S M & D'Agostino, G 2021, ' Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation ', Molecular Metabolism, vol. 55, 101407 . https://doi.org/10.1016/j.molmet.2021.101407Test
Molecular Metabolism
Molecular Metabolism, Vol 55, Iss, Pp 101407-(2022)

مصطلحات موضوعية: Blood Glucose, Male, Glucagon-like peptide-1, endocrine system, Glucose-dependent insulinotropic polypeptide, media_common.quotation_subject, Appetite, Gastric Inhibitory Polypeptide, Brief Communication, Glucagon-Like Peptide-1 Receptor, Receptors, Gastrointestinal Hormone, Mice, Nucleus of the solitary tract, Glucagon-Like Peptide 1, Appetite Depressants, Medicine, Animals, Hypoglycemic Agents, Insulin, Receptor, Internal medicine, Molecular Biology, Glucagon-like peptide 1 receptor, media_common, Cholecystokinin, Neurons, business.industry, Area postrema, digestive, oral, and skin physiology, Brain, Nausea, Cell Biology, Liraglutide, Glucagon, RC31-1245, Mice, Inbred C57BL, Anorectic, Exenatide, Female, Brainstem, business, Neuroscience, hormones, hormone substitutes, and hormone antagonists

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c8f4b8195f8ad7f7f17bc35a2d9541Test
https://www.research.manchester.ac.uk/portal/en/publications/anorectic-and-aversive-effects-of-glp1Test-receptor-agonism-are-mediated-by-brainstem-cholecystokinin-neurons-and-modulated-by-gip-receptor-activation(97b025ca-ff46-4b48-a59c-edf8df09098e).html

4

Sgemaglutide in type 2 diabetes – is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?

المؤلفون: Sheila A Doggrell

المصدر: Expert Opinion on Drug Metabolism & Toxicology. 14:371-377

مصطلحات موضوعية: Agonist, endocrine system, medicine.medical_specialty, medicine.drug_class, media_common.quotation_subject, Glucagon-Like Peptides, 030204 cardiovascular system & hematology, Toxicology, Drug Administration Schedule, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Insulin Secretion, medicine, Humans, Hypoglycemic Agents, Insulin, 030212 general & internal medicine, Glucagon-like peptide 1 receptor, Aged, media_common, Pharmacology, Dose-Response Relationship, Drug, Liraglutide, Chemistry, Semaglutide, digestive, oral, and skin physiology, Glucagon secretion, Appetite, General Medicine, Endocrinology, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Exenatide, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f46fcabc6218d4ccb8160aa5f0465caaTest
https://doi.org/10.1080/17425255.2018.1441286Test

5

Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes

المؤلفون: Melanie Kahle, Michael A. Nauck, Oleg Baranov, Carolyn F. Deacon, Jens J. Holst

المصدر: Diabetes, Obesity and Metabolism. 19:200-207

مصطلحات موضوعية: Adult, Blood Glucose, Male, endocrine system, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Incretin, 030209 endocrinology & metabolism, Gastric Inhibitory Polypeptide, Type 2 diabetes, Dipeptidyl peptidase-4 inhibitor, 030204 cardiovascular system & hematology, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Glucagon-Like Peptide 1, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Insulin, Glucagon-like peptide 1 receptor, Aged, Glycated Hemoglobin, Dipeptidyl-Peptidase IV Inhibitors, Cross-Over Studies, C-Peptide, business.industry, Liraglutide, Sitagliptin Phosphate, digestive, oral, and skin physiology, Glucagon secretion, Middle Aged, Glucagon, medicine.disease, Metformin, Treatment Outcome, Diabetes Mellitus, Type 2, Sitagliptin, Drug Therapy, Combination, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aeb4238ac03c2f73dff6a121ec9ef2cTest
https://doi.org/10.1111/dom.12802Test

6

Different mechanisms involved in liraglutide and glucagon‐like peptide‐1 vasodilatation in rat mesenteric small arteries

المؤلفون: Daniel Dias Rufino Arcanjo, Michael Gejl, Khiem Dinh Huynh, Jakob S. Knudsen, Alejandro Gutierrez, Ulf Simonsen, Asbjørn Graver Petersen, Jørgen Rungby, Maj Bangshaab

المصدر: Bangshaab, M, Gutierrez, A, Huynh, K D, Knudsen, J S, Arcanjo, D D R, Petersen, A G, Rungby, J, Gejl, M & Simonsen, U 2019, ' Different mechanisms involved in liraglutide and glucagon-like peptide-1 vasodilatation in rat mesenteric small arteries ', British Journal of Pharmacology, vol. 176, no. 3, pp. 386-399 . https://doi.org/10.1111/bph.14534Test

مصطلحات موضوعية: Male, 0301 basic medicine, PHARMACOKINETICS, endocrine system, medicine.medical_specialty, EXENATIDE, medicine.drug_class, medicine.medical_treatment, Myocytes, Smooth Muscle, Bradykinin, BLOOD-PRESSURE, Vasodilation, ENDOTHELIUM-DEPENDENT RELAXATION, Glucagon-Like Peptide-1 Receptor, GLUCOSE, ACTIVATION, Structure-Activity Relationship, 03 medical and health sciences, chemistry.chemical_compound, Glucagon-Like Peptide 1, Superoxides, Internal medicine, medicine, Animals, Rats, Wistar, Receptor, Mesenteric arteries, Pharmacology, Dose-Response Relationship, Drug, Liraglutide, Insulin, digestive, oral, and skin physiology, Receptor antagonist, CONCISE GUIDE, RECEPTOR AGONISTS, Research Papers, Glucagon-like peptide-1, Mesenteric Arteries, Rats, 030104 developmental biology, Endocrinology, medicine.anatomical_structure, chemistry, GLP-1, RESISTANCE, hormones, hormone substitutes, and hormone antagonists, medicine.drug